TI
RPTX

Trexquant Investment’s Repare Therapeutics RPTX Stock Holding History

Trexquant Investment’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-29,456
Closed -$356K – 1728
2023
Q3 		$356K Sell
29,456
-26,476
-47% -$273K 0.01% 1157
2023
Q2 		$592K Sell
55,932
-32,206
-37% -$332K 0.02% 942
2023
Q1 		$867K Buy
88,138
+15,520
+21% +$178K 0.02% 786
2022
Q4 		$1.07M Sell
72,618
-7,056
-9% -$106K 0.03% 622
2022
Q3 		$966K Buy
79,674
+28,447
+56% +$366K 0.03% 543
2022
Q2 		$717K Buy
+51,227
New +$603K 0.03% 650
2022
Q1 		– Sell
-20,333
Closed -$429K – 1665
2021
Q4 		$429K Buy
20,333
+5,817
+40% +$137K 0.03% 730
2021
Q3 		$381K Buy
+14,516
New +$469K 0.03% 646

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Trexquant Investment's RPTX Position: Q4 2023 in Review

Trexquant Investment sold out of Repare Therapeutics (RPTX) in Q4 2023, closing a stake of 29,456 shares — an estimated $356K sold.

Trexquant Investment first reported a position in RPTX in Q3 2021 and held it in 8 quarters. The position peaked at $1.07M in Q4 2022. 69 funds tracked by Wall St. Rank hold RPTX as of Q4 2023.

  • Trexquant Investment reported no remaining Repare Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Trexquant Investment sold 29,456 Repare Therapeutics shares in Q4 2023, an estimated $356K.
  • Trexquant Investment first reported a position in Repare Therapeutics in Q3 2021 and held it in 8 quarters.
  • Trexquant Investment's Repare Therapeutics position peaked at $1.07M in Q4 2022.
  • 69 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2023.

Based on Trexquant Investment's 13F filing for Q4 2023, filed 9 Feb 2024.